REG - Wilmington PLC - Trading Statement

WilmingtonAnnouncement

23/07/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250723:nRSW1038Sa&default-theme=true

RNS Number : 1038S  Wilmington PLC  23 July 2025

23 July 2025

Wilmington plc

 

Year-end trading update

 

Wilmington plc, (LSE: WIL, 'Wilmington', 'the Group') the provider of data,
information, education and training in the global Governance, Risk and
Compliance ('GRC') markets, today provides a trading update for the year ended
30 June 2025.

 

Revenue growth from the Group's ongoing* businesses is expected to be 11%, led
by both recent acquisitions in the HSE sector delivering double-digit
percentage growth.

 

As at the half year, seven out of nine businesses grew year on year. Following
the portfolio changes last year of two disposals and two acquisitions, and the
continuing disruption in the US healthcare insurance market impacting our US
events business over a full year, reported revenue is expected to be £101.5m
(2024:  £126m), with organic** revenue also having decreased 1% due to the
US.

 

Operating profit from ongoing* businesses is expected to be up 11%,
adjusted*** profit before tax is expected to be £27.7m (2024: £27.6m), with
adjusted PBT margin up to 27% (2024: 22%).

 

Cash conversion continued to be strong at 107% of profits, with Group net cash
on 30 June 2025 at £41.9m (30 June 2024: £67.8m) after the completion of the
acquisition of Phoenix Health & Safety on 25 October 2024 and spending
£3.4m on share buybacks.

 

Wilmington expects to publish its year end results on 22 September 2025.

 

Mark Milner, Chief Executive Officer, commented:

 

"We have seen another year of good ongoing* revenue and profit growth with
both measures increasing 11%, reflecting our focus on a slimmed down higher
quality portfolio of growing businesses. Margins have also continued to
improve and both of our recent acquisitions have seen double digit growth.
This performance came against a tough macro backdrop, particularly in the US
healthcare market which has seen continued disruption in the course of our H2.

 

"With the acquisition of Phoenix, we have continued to actively manage our
portfolio of businesses and are pursuing various opportunities to invest our
cash in acquisitions to improve the quality of revenue and profits."

 

*Ongoing - eliminating the effects of the impact of disposals, closures and
businesses held for sale.

**Organic - Ongoing, eliminating acquisitions and exchange rate fluctuations

***Adjusted profit before tax (PBT) is calculated as PBT after adding back
amortisation and impairment of intangible assets (except computer software)
and profits/losses on disposals and business closures. Market consensus
adjusted profit before tax is £27.0m.

 

 For further information, please contact:

 Wilmington plc                              020 7490 0049

 Mark Milner, Chief Executive Officer

 Guy Millward, Chief Financial Officer

 Meare Consulting

07990 858548
 Adrian Duffield

 

The information contained within this announcement is deemed to constitute
inside information as stipulated under the Market Abuse Regulations (EU) No.
596/2014. Upon the publication of this announcement this inside information is
now considered to be in the public domain.

 

Notes to Editors

Wilmington plc is the recognised knowledge leader and partner of choice for
data, information, education and training in the global Governance, Risk and
Compliance (GRC) markets. Wilmington employs around 600 people and sells to
around 120 countries. Wilmington is listed on the main market of the London
Stock Exchange.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TSTUUUORVWUBUAR